Videoendoscopic Drainage of Infected Pancreatic Collections

Pancreatitis, Acute Necrotizing Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00061269
• Other study ID #: VDIPC (completed)
• Secondary ID: R03DK061362
• Status: Completed
• Phase: N/A
• Start date: September 2003
• Est. completion date: September 2008

Study information

• Verified date: September 2018
• Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The VARD (Videoendoscopic Assisted Retroperitoneal Drainage) approach as treatment for necrotizing pancreatitis proposes an alternative to standard complicated open abdomen treatment methods.

This treatment involves making a small incision and looking inside the abdomen with a videoendoscope. A videoendoscope is an instrument with a small camera and light on the end. It also has an extension tool that the surgeon can use to clean out any dead and infected tissue in the abdomen.

This approach may reveal a treatment opportunity with faster recovery potential and shorter hospitalizations for patients with necrotizing pancreatitis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 40
• Est. completion date: September 2008
• Est. primary completion date: September 2008
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

• Pancreatic necrosis or peripancreatic fluid collection following acute pancreatitis noted on CT scan

• Infected pancreatic necrosis or pancreatic abscess and determined by + FNA (gram stain or culture), as defined by the Atlanta Symposium

• Not neutropenic or pregnant

• No prior necrosectomy

• No pancreatic pseudocyst, either sterile or infected

Related Conditions & MeSH terms

• Pancreatitis
• Pancreatitis, Acute Necrotizing

Intervention

Procedure:
• Videoscopic-Assisted Retroperitoneal Debridement (VARD)

Locations

Country	Name	City	State
Canada	University of Toronto	Toronto	Ontario
United States	Oregon Health Sciences University	Portland	Oregon
United States	Veteran's Administration-Portland	Portland	Oregon
United States	Harborview Medical Center	Seattle	Washington
United States	University of Washington	Seattle	Washington
United States	Veteran's Administration Puget Sound	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Countries where clinical trial is conducted

United States,  Canada,